header

Evaluation of asymmentric dimethylarginine as a novel risk factor for cardiovascular patients /

Mohamed Saied Shaban Moafy

Evaluation of asymmentric dimethylarginine as a novel risk factor for cardiovascular patients / تقييم دور ثنائى ميثيل الارجنين الغير متماثل كعامل خطر وذلك فى مرضى القلب والاوعية الدموية Mohamed Saied Shaban Moafy ; Supervised Abdelgawaad Ali Fahmi , Mohammed Islam , Osama Mohamed Tayeh - Cairo : Mohamed Saied Shaban Moafy , 2010 - 237P. : charts , facsimiles ; 25cm

Thesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry

This study is an attempt to investigate the physiological and biochemical roles of plasma asymmetric dimethylarginine (ADMA) as a new risk factor in patients with cardiovascular diseases . It is concluded from the results of the present investigation that plasma asymmetric dimethylarginine levels were significantly higher in cardiovascular patients than healthy subjects



Asymmetric dimethylarginine Cardiovascular disease Hypertension